Progress in non-classical antitumor platinum drugs

Progress in Chemistry

Volumn 16, Issue 3, 2004, Pages 456-462

  Wang, Lianhong ^a,b   Liu, Yun ^b   You, Qidong ^a   Gou, Shaohua ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Antitumor mechanism; Antitumor platinum drugs; Cross resistance; Non classical structure activity relationship; Orally activity

Indexed keywords

ANTINEOPLASTIC AGENT; BBR 3464; BBR 3610; CISPLATIN; IPROPLATIN; PLATINUM DERIVATIVE; SULFUR; TETRAPLATIN; TRANSPLATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; REVIEW;

EID: 11144294858     PISSN: 1005281X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Orr R M, O'Neill C F, Nicolson M C, et al. Br. J. Cancer, 1994, 70: 415-420
2. Kelland L R, Murrer B A, Abel G, et al. Cancer Research, 1992, 52: 822-828
3. Lemma K, House D A, Retta N, et al. Inorganica Chimica Acta, 2002, 331: 98-108
4. Drugs Fut., 1993, 18 (7): 663
5. Drugs Fut., 2000, 25 (6): 650-651
6. Fokkema E, de Vries E G, Meijer S, et al. Cancer Chemother. Pharmacol., 2000, 45 (1): 89-92
7. Anon N Z, Drugs in R&D, 2002, 3(1): 67-71
8. Siddik Z H, Al-Baker S, Khokhar A R, et al. J. Cancer Res. Clin. Oncol., 1994, 120 (7): 409-414
9. Lee Y A, Lee S S, Kim K M, et al. J. Med. Chem., 2000, 43 (7): 1 409-1 412
10. Drugs Fut., 1996, 21 (3): 220
11. Shao W P, Guan Y T, Tang W X, Chinese Journal of Applied Chemistry, 1992, 9 (6): 57-60
12. Shamsuddin S, Santillan C C, Stark JL, et al. J. Inorg. Biochem., 1998, 71 (1/2): 29-35
13. Mogi K, Koya H, Ohtsuka M, et al. EP 864 578 A2, 1998
14. Shimizu H, Kato M. JP 02 028 135 A2, 1990
15. Noji M, Sumi M, Ohmori T, et al. Nippon Kagaku Kaishi, 1988, (4): 675-683
16. Verbeek F, Bulten E J, Berg J. DE 3 207 472 A1, 1982
17. Zhu H J, Feng J M, Tang W X, Journal of Nanjing University, 1989, 25 (2): 314-321
18. Drugs Fut., 2000, 25 (10): 1083-1084
19. Holford J, Beale P J, Boxall F E. Eur. J. Cancer, 2000, 36 (15): 1984-1990
20. Hotze A C G, Chen Y, Hambley T W, et al. European Journal of Inorganic Chemistry, 2002, (5): 1035-1039
21. Bloemink M J, Engelking H, Karentzopoulos S, et al. Inorg. Chem., 1996, 35: 619-627
22. Sakai K, Tomita Y, Ue T, et al. Inorg. Chim. Acta, 2000, 297 (1/2): 64-71
23. Pharma Projects. UK: PJB Publications Ltd., May 1998. a1756
24. Gund A, Keppler B K. Angew. Chem. Int. Ed. Engl., 1994, 33 (2): 186-188
25. Yoo J, Sohn Y S, Do Y J. Inorg. Biochem., 1999, 73 (3): 187-193
26. Pharma Projects. UK: PJB Publications Ltd., May 1997. a1661
27. Yam V W, Tang R P, Wong K M. Inorg. Chem., 2001, 40 (3): 571-574
28. Talarico T, Phillips D R, Deacon G B, et al. Invest. New Drugs, 1999, 17 (1): 1-15
29. Bierbach U, Qu Y, Hambley T, et al. Inorg. Chem., 1999, 38 (15): 3535-3542
30. Farrell N. US 6 350 740 B1, 2002
31. Khazanov E, Barenholz Y, Gibson D, et al. J. Med. Chem., 2002, 45: 5196-5204
32. Bierbach U, Sabat M, Farrell N. Inorg. Chem., 2000, 39 (9): 1882-1890
33. Coluccia M, Nassi A, Loseto F, et al. J. Med. Chem., 1993, 36: 510-512
34. Montero E I, Diaz S, Gonzalez-Vadillo A M. J. Med. Chem., 1999, 42 (20): 4264-4268
35. Kelland L R, Barnard F J, Evans I G, et al. J. Med. Chem., 1995, 38 (16): 3016-3024
36. Kelland L R, Barnard C F J, Mellish K J, et al. Cancer Res., 1994, 54 (21): 5618-5622
37. Lemma K, Shi T, Elding L I, et al. Inorg. Chem., 2000, 39 (8): 1728-1734
38. O' Neill C F, Hunakova L, Kelland L R. Chem.-Biol. Interact., 1999, 123 (1): 11-29
39. Farrell N P, Menta E, Di D, et al. US 6 060 616, 2000
40. Kloster M B G, Hannis J C, Muddiman D C, et al. Biochemistry, 1999, 38(45): 14731-14737
41. Pharma Projects. UK: PJB Publications Ltd., May 2001. a1825
42. Davies M S, Thomas D S, Hegmans A, et al. Inorganic Chemistry, 2002, 41(5): 1101-1109
43. Kraker A J, Hoeschele J D, Elliott W L, et al. J. Med. Chem., 1992, 35: 4526-4532
44. Jansen B A J, van der Zwan J, den Dulk H, et al. J. Med. Chem., 2001, 44(2): 245-249
45. Komeda S, Lutz M, Spek A L, et al. Inorg. Chem., 2000, 39 (19): 4230-4236
46. Komeda S, Lutz M, Spek AL, et al. Journal of the American Chemical Society, 2002, 124 (17): 4738-4746
47. Sachinvala N D, Chen H, Niemczura W. J. Med. Chem., 1993, 36: 1791-1795
48. Quiroga A G, Perez J M, Lopez-Solera I, J. Med. Chem., 1998, 41 (9): 1399-1408
49. Miller A, Amundsen A R, Stern E W, et al. EP 0 290 169, 1988
50. Farrell N, Kiley D M, Schmidt W, et al. Inorg. Chem., 1990, 29 (3): 397-403
51. Shamsuddin S, Al-Baker S, Siddik Z H, et al. Inorg. Chim. Acta, 1996, 241 (2): 101-104
52. Bierbach U, Hambley T W, Farrell N, et al. Inorg. Chem., 1998, 37 (4): 708-716
53. Martins E T, Baruah H, Kramarczyk J, et al. J. Med. Chem., 2001, 44: 4492-4496
54. Sacht C, Datt M S. Polyhedron, 2000, 19 (11): 1347-1354
55. Sacht C, Datt M S, Otto S, et al. J. Chem. Soc. Dalton, 2000, (5): 727-733
56. Henderson W, McCaffrey L J, Nicholson B K, et al. J. Chem. Soc. Dalton, 2000, (16): 2753-2760
57. Jain N, Srivastava T S, Satyamoorthy K. J. Inorg. Biochem., 1988, 33(1): 1-9
58. Amtmann E, Zoller M, Wesch H, et al. Cancer Chemother. Pharmacol., 2001, 47 (6): 461-466
59. Pharma Projects. UK: PJB Publications Ltd., May 2001. a1836
60. Onoa G B, Moreno V, Freisinger E, et al. Journal of Inorganic Biochemistry, 2002, 89 (3/4): 237-247
61. Gust R, Heinrich H, Krauser R. Inorg. Chim. Acta, 1999, 285 (2): 184-189